10th Annual Edinburgh Infectious Diseases Symposium

Keeping Connected - Edinburgh Infectious Disease Symposium 2021

As ever we are celebrating the range of infectious disease research from across Edinburgh.  We are also very pleased to welcome Prof Stewart Cole, President of the Institut Pasteur, as the Ker Memorial Lecturer.  

Details of the fully-online programme are below.  Any updates to speakers or the schedule will be available on the symposium website.  We very much hope that you will be able to join us.  Please note that spaces are limited to 250 participants.

Programme

09.15:  Ross Fitzgerald (Director of Edinburgh Infectious Diseases) – Welcome and introduction

09.20:  Ker Lecture: Stewart Cole (President of the Institut Pasteur, Paris) – Accelerating tuberculosis drug development

10.05 – Break

10.15:  Aaron Trent Irving (Zhejiang University-University of Edinburgh Institute, Zhejiang) ­– Bats as reservoirs of zoonotic coronaviruses

10.35:  Katie Atkins (Usher Institute) – Combining mathematical models and phylogenetics to understand SARS-CoV-2 and HIV

10.55:  Adam Hayward (Moredun Research Institute) – Quantifying the impact of liver fluke on performance in beef cattle

 11.15:  Early career reearcher short talks x 6

  1. Enock Mararo (Roslin Institute) – Comparative metabolomics of Trypanosoma brucei and Trypanosoma congolense and their impact on macrophage function and host immune responses
  2. Wiebke Nahrendorf (School of Biological Sciences) – Adaptive T cells regulate disease tolerance in human malaria
  3. Cristina Moreno Lozano (Science, Technology and Innovation Studies) – Optimizing antibiotics: Antibiotic stewardship, medical work and resistant microbes in public hospitals in democratic Spain
  4. Clark Russell (Centre for Inflammation Research) – Pathogen adaptation identifies macrophage targets for host-directed therapies
  5. Sara Clohisey (Roslin Institute) – Genetic mechanisms of critical illness in COVID-19
  6. Lois King (Usher Institute) – Addressing childhood pneumonia in a post-COVID world: power, political priorities and progress

11.35  – Break

 11.45:  Ker Prize Winner (TBC)

12.00:  Christine Tait-Burkard (Roslin Institute) – IFN alpha variants as a treatment and immune-stimulant against SARS-CoV-2 infection

12.20:  Maddie Moule (School of Biological Sciences) – Dissecting the host-pathogen interactions of Mycobacterium tuberculosis dissemination and extrapulmonary spread

12.40:  Dominic Moran (Global Academy of Agriculture and Food Security) – Antimicrobial resistance: an economic primer